Nanobiotix S.A. Shortterm Employee Benefits Expense
Nanobiotix S.A. (NBTX) reported Shortterm Employee Benefits Expense of EUR 20.80 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ShorttermEmployeeBenefitsExpense · last filed 2026-03-31
| Period end | Shortterm Employee Benefits Expense 12 month |
|---|---|
| 2025-12-31 | 20.80M EUR 20-F · filed 2026-03-31 |
| 2024-12-31 | 20.00M EUR 20-F · filed 2026-03-31 |
| 2023-12-31 | 19.20M EUR 20-F · filed 2026-03-31 |
| 2022-12-31 | 17.30M EUR 20-F · filed 2025-04-02 |
| 2021-12-31 | 15.70M EUR 20-F · filed 2024-04-24 |
| 2020-12-31 | 15.10M EUR 20-F · filed 2023-04-24 |
| 2019-12-31 | 16.80M EUR 20-F · filed 2022-04-08 |
| 2018-12-31 | 13.80M EUR 20-F/A · filed 2021-04-08 |